98
Nanjing Leads Biolabs Co Ltd
9887.HK · HKSE
$63.00 -0.47% (-$0.30)
1M -4.67%
Market Cap ¥10.7B
P/E Ratio -
Div. Yield -
ROE 9.67%
Piotroski F-Score Moderate
4/9Valuation
3 /100
Expensive P/B 7.61x
P/S 54.85x
PEG N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
20 /100
Weak FCF margin 13.68%
Op. margin 28.06%
Gross margin 100.00%
Quality
1 /100
Poor Asset turnover 0.10x
ROA 3.77%
ROIC 4.14%
Debt
69 /100
Low Current ratio 3.37x
Int. coverage -15.10x
Debt/Equity 0.22x
Stability
17 /100
Unstable EPS volatility 229.73%
Profitable years 0
Beta 1.37x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 9887.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Xiaoqiang Kang
Employees
244
Headquarters
Nanjing
Evenimente viitoare
29 MAR.
Earnings
Upcoming earnings report